ARTICLE | Clinical News
LXR regulatory update
October 27, 1997 8:00 AM UTC
LXR received U.S. Patents Nos. 5,652,210 and 5,663,070 relating to the Fas delta gene and its encoded protein, which is the naturally occurring form of the Fas receptor involved in signaling cell dea...